Rislenemdaz

A potent, orally bioavailable brain‐penetrant, NR2B-selective NMDA receptor (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM respectively.

808732-98-1

≥ 2 years

>98% (HPLC)

358.417

C19H23FN4O2

Research use only, not for human use.

IGluR

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

EF012830 96 Tests

Ask

DAG-25AT10-H 25 mL

Ask

MF-0156813-01 5 mg

Ask

MF-0156813-02 50 mg

Ask

bs-7053R-PE 100 µL

Ask

E51K1935 40 µL

Ask